Dihydroartemisinin-piperaquine versus chloroquine in the treatment of plasmodium vivax malaria in Thailand: A randomized controlled trial
Background. Chloroquine (CQ) remains the treatment of choice for Plasmodium vivax malaria. Initially confined to parts of Indonesia and Papua, resistance of P. vivax to CQ seems to be spreading, and alternative treatments are required. Methods. We conducted a randomized controlled study to compare t...
Saved in:
Main Authors: | Aung Pyae Phyo, Khin Maung Lwin, Ric N. Price, Elizabeth A. Ashley, Bruce Russell, Kanlaya Sriprawat, Niklas Lindegardh, Pratap Singhasivanon, Nicholas J. White, François Nosten |
---|---|
Other Authors: | Shoklo Malaria Research Unit |
Format: | Review |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/12219 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: An open randomized, non-inferiority, trial
by: Ghulam Rahim Awab, et al.
Published: (2018) -
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
by: Khin Maung Lwin, et al.
Published: (2018) -
Dihydroartemisinin-piperaquine versus
chloroquine to treat vivax malaria in Afghanistan: an open randomized,non-inferiority, trial
by: Awab, Ghulam Rahim, et al.
Published: (2010) -
Chloroquine versus dihydroartemisinin-piperaquine with standard high-dose primaquine given either for 7 days or 14 days in plasmodium vivax malaria
by: Cindy S. Chu, et al.
Published: (2020) -
A randomized comparison of chloroquine versus dihydroartemisinin-piperaquine for the treatment of plasmodium vivax infection in Vietnam
by: Phung Duc Thuan, et al.
Published: (2018)